Cymabay Therapeutics Overview

Cymabay Therapeutics Other Income Expense Net

Other Income/Expense Net for CBAY.

Quarterly Other Income/Expense

$596000.00

↑ 118.88% YoY

As of Dec 31, 2023

Annual Other Income/Expense (TTM)

-$1.70M

↑ 86.81% YoY

Trailing 12 months ending Dec 31, 2023

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin